Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
La Revue De Medecine Interne|August 21, 2007
[Efficiency of rituximab in acquired hemophilia: report of two cases and review of literature]A Millet, O Decaux, B Bareau, et al.British Journal of Haematology|September 21, 2001
Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophiliaB Guillet, F Kriaa, M G Huysse, et al.Journal of Thrombosis and Haemostasis : JTH|June 29, 2012
Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potentialY Bennis, G Sarlon-Bartoli, B Guillet, et al.ACS Applied Materials & Interfaces|February 11, 2026
Tuning Strain by Varying CaTiO<sub>3</sub> Thickness in Heteroepitaxially Grown La<sub>2/3</sub>Sr<sub>1/3</sub>MnO<sub>3</sub> Double-Clamped Resonators on SiliconG Tarsi, N Manca, L Pellegrino, et al.Cardiovascular and Interventional Radiology|April 27, 2019
In Vivo Feasibility of Arterial Embolization with Permanent and Absorbable Suture: The FAIR-Embo ConceptV Vidal, J F Hak, P Brige, et al.Oncogene|April 12, 2016
Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumorsJ Stalin, M Nollet, P Garigue, et al.Thrombosis Research|March 31, 2024
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patientsH Lévesque, J F Viallard, E Houivet, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|August 18, 2017
Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect StudyR J Liesner, M Abashidze, O Aleinikova, et al.Pageof 2